215 related articles for article (PubMed ID: 22554960)
1. Encapsulated papillary carcinoma of the breast: a study of invasion associated markers.
Rakha EA; Tun M; Junainah E; Ellis IO; Green A
J Clin Pathol; 2012 Aug; 65(8):710-4. PubMed ID: 22554960
[TBL] [Abstract][Full Text] [Related]
2. Are encapsulated papillary carcinomas of the breast in situ or invasive? A basement membrane study of 27 cases.
Esposito NN; Dabbs DJ; Bhargava R
Am J Clin Pathol; 2009 Feb; 131(2):228-42. PubMed ID: 19141383
[TBL] [Abstract][Full Text] [Related]
3. Expression of E-cadherin, beta-catenin, cathepsin D, gelatinases and their inhibitors in invasive ductal breast carcinomas.
Zhang YG; DU J; Tian XX; Zhong YF; Fang WG
Chin Med J (Engl); 2007 Sep; 120(18):1597-605. PubMed ID: 17908479
[TBL] [Abstract][Full Text] [Related]
4. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
[TBL] [Abstract][Full Text] [Related]
5. Encapsulated papillary carcinoma of the breast: an invasive tumor with excellent prognosis.
Rakha EA; Gandhi N; Climent F; van Deurzen CH; Haider SA; Dunk L; Lee AH; Macmillan D; Ellis IO
Am J Surg Pathol; 2011 Aug; 35(8):1093-103. PubMed ID: 21753694
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
Impola U; Uitto VJ; Hietanen J; Hakkinen L; Zhang L; Larjava H; Isaka K; Saarialho-Kere U
J Pathol; 2004 Jan; 202(1):14-22. PubMed ID: 14694517
[TBL] [Abstract][Full Text] [Related]
7. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
8. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
9. Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas.
Nielsen BS; Rank F; López JM; Balbin M; Vizoso F; Lund LR; Danø K; López-Otín C
Cancer Res; 2001 Oct; 61(19):7091-100. PubMed ID: 11585740
[TBL] [Abstract][Full Text] [Related]
10. Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion.
Okumura Y; Yamamoto Y; Zhang Z; Toyama T; Kawasoe T; Ibusuki M; Honda Y; Iyama K; Yamashita H; Iwase H
BMC Cancer; 2008 Oct; 8():287. PubMed ID: 18837981
[TBL] [Abstract][Full Text] [Related]
11. Tumour markers in breast carcinoma correlate with grade rather than with invasiveness.
Wärnberg F; Nordgren H; Bergkvist L; Holmberg L
Br J Cancer; 2001 Sep; 85(6):869-74. PubMed ID: 11556839
[TBL] [Abstract][Full Text] [Related]
12. A subset of in situ breast tumor cell clusters lacks expression of proliferation and progression related markers but shows signs of stromal and vascular invasion.
Man YG; Shen T; Weisz J; Berg PE; Schwartz AM; Mulshine JL; Sang QX; Nieburgs HE
Cancer Detect Prev; 2005; 29(4):323-31. PubMed ID: 16122886
[TBL] [Abstract][Full Text] [Related]
13. Study of matrix metalloproteinases and their tissue inhibitors in ductal in situ carcinomas of the breast.
Gonzalez LO; Corte MD; Vazquez J; Junquera S; Sanchez R; Viña A; Rodriguez JC; Lamelas ML; Vizoso F
Histopathology; 2008 Oct; 53(4):403-15. PubMed ID: 18983606
[TBL] [Abstract][Full Text] [Related]
14. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer.
Choi Y; Lee HJ; Jang MH; Gwak JM; Lee KS; Kim EJ; Kim HJ; Lee HE; Park SY
Hum Pathol; 2013 Nov; 44(11):2581-9. PubMed ID: 24055090
[TBL] [Abstract][Full Text] [Related]
15. [Expressions of receptor-binding cancer antigen expressed on SiSo cells, vascular endothelial growth factor, and matrix metalloproteinase-9 in cervical carcinoma and correlation thereof with the invasion and metastasis of the cancerous tissues].
Liu R; Pu DM; Cheng YX; Yin L
Zhonghua Yi Xue Za Zhi; 2007 May; 87(19):1326-9. PubMed ID: 17727777
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis.
Yang Q; Ye ZY; Zhang JX; Tao HQ; Li SG; Zhao ZS
Anat Rec (Hoboken); 2010 Dec; 293(12):2012-9. PubMed ID: 21089052
[TBL] [Abstract][Full Text] [Related]
17. Concomitant expression of epithelial-mesenchymal transition biomarkers in breast ductal carcinoma: association with progression.
Logullo AF; Nonogaki S; Pasini FS; Osório CA; Soares FA; Brentani MM
Oncol Rep; 2010 Feb; 23(2):313-20. PubMed ID: 20043090
[TBL] [Abstract][Full Text] [Related]
18. Tissue distribution of major matrix metalloproteinases and their transcripts in human breast carcinomas.
Lebeau A; Nerlich AG; Sauer U; Lichtinghagen R; Löhrs U
Anticancer Res; 1999; 19(5B):4257-64. PubMed ID: 10628384
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of matrix metalloproteinases in squamous cell carcinoma of the tongue and lower lip.
Barros SS; Henriques ÁC; Pereira KM; de Medeiros AM; Galvão HC; Freitas Rde A
Arch Oral Biol; 2011 Aug; 56(8):752-60. PubMed ID: 21255765
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinase 1 in benign and malignant breast tissue--strong expression in intraductal carcinomas of the breast.
Rahko E; Kauppila S; Pääkkö P; Blanco G; Apaja-Sarkkinen M; Talvensaari-Mattila A; Turpeenniemi-Hujanen T; Jukkola A
Tumour Biol; 2009; 30(5-6):257-64. PubMed ID: 19887890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
